Female pattern hair loss. Other androgenic alopecia
Conditions
Interventions
Intervention 1: First interventional group: Dutasteride solution 60/ml which contain the active ingredient Dutasteride with a concentration of 0.1% mg/ml was prepared by pharmacists in Tasnim Pharmace
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age more than 18 year old clinical and trichoscopic diagnosis of female pattern hair loss female patients Female pattern hair loss grade 1-3 ludwig scale
Exclusion criteria
Exclusion criteria: Past history of treatment of AGA in the last three months Alcoholism or addicted Past history of hair transplant systemic diseases or dermatological diseases that may affect hair regrowth Sensitivity to topical dutasteride Sexual dysfunction Current treatment for AGA Lactation and pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and percentage of terminal and vellous hair, in addition to diameter of the hair terminals. Timepoint: Number and percentage of terminal and vellous hair, in addition to diameter of the hair terminals before intervention, 3 months after intervention and lastly 6 months after intervention. Method of measurement: Trichoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall increase in hair density. Timepoint: initially, after 3 months and lastly after 6 months. Method of measurement: trichscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaman Alzahawi
Tehran University of Medical Sciences
Outcome results
None listed